skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 75,865  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Journal Title: Blood remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Malignant progression of preleukemic disorders
Material Type:
Article
Add to My Research

Malignant progression of preleukemic disorders

Blood, 2024-05, Vol.143 (22), p.2245-2255 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023020817 ;PMID: 38498034

Full text available

2
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
Material Type:
Article
Add to My Research

Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee

Blood, 2024-05, Vol.143 (22), p.2227-2244 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023023476 ;PMID: 38493484

Full text available

3
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia
Material Type:
Article
Add to My Research

Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia

Blood, 2024-05 [Peer Reviewed Journal]

Copyright © 2024 American Society of Hematology. ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2024023890 ;PMID: 38805638

Full text available

4
IL-1 in Aging and Pathologies of Hematopoietic Stem Cells
Material Type:
Article
Add to My Research

IL-1 in Aging and Pathologies of Hematopoietic Stem Cells

Blood, 2024-05 [Peer Reviewed Journal]

2024 American Society of Hematology ;Copyright © 2024 American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023023105 ;PMID: 38781562

Full text available

5
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy
Material Type:
Article
Add to My Research

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy

Blood, 2024-05, Vol.143 (21), p.2152-2165 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023023381 ;PMID: 38437725

Full text available

6
Targeting the TNF/IAP pathway synergizes with anti-CD3 immunotherapy in T-cell acute lymphoblastic leukemia
Material Type:
Article
Add to My Research

Targeting the TNF/IAP pathway synergizes with anti-CD3 immunotherapy in T-cell acute lymphoblastic leukemia

Blood, 2024-05, Vol.143 (21), p.2166-2177 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023022455 ;PMID: 38437728

Full text available

7
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain
Material Type:
Article
Add to My Research

Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain

Blood, 2024-05, Vol.143 (21), p.2178-2189 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023023120 ;PMID: 38394665

Full text available

8
Smoldering multiple myeloma: taking the narrow over the wide path?
Material Type:
Article
Add to My Research

Smoldering multiple myeloma: taking the narrow over the wide path?

Blood, 2024-05, Vol.143 (20), p.2025-2028 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2024023880 ;PMID: 38427775

Full text available

9
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children’s Oncology Group trial AALL1231
Material Type:
Article
Add to My Research

MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children’s Oncology Group trial AALL1231

Blood, 2024-05, Vol.143 (20), p.2053-2058 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023021184 ;PMID: 38457359

Full text available

10
Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis
Material Type:
Article
Add to My Research

Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis

Blood, 2024-05, Vol.143 (20), p.2089-2098 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023021265 ;PMID: 38271661

Full text available

11
Platelet dysfunction reversal with cold-stored vs room temperature–stored platelet transfusions
Material Type:
Article
Add to My Research

Platelet dysfunction reversal with cold-stored vs room temperature–stored platelet transfusions

Blood, 2024-05, Vol.143 (20), p.2073-2088 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023022593 ;PMID: 38427589

Full text available

12
Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma
Material Type:
Article
Add to My Research

Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma

Blood, 2024-05, Vol.143 (20), p.2029-2036 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023023597 ;PMID: 38394666

Full text available

13
How I treat challenging transfusion cases in sickle cell disease
Material Type:
Article
Add to My Research

How I treat challenging transfusion cases in sickle cell disease

Blood, 2024-05 [Peer Reviewed Journal]

2024 American Society of Hematology ;Copyright © 2024 American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023023648 ;PMID: 38728382

Full text available

14
let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching
Material Type:
Article
Add to My Research

let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching

Blood, 2024-05, Vol.143 (19), p.1980-1991 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023023399 ;PMID: 38364109

Full text available

15
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission
Material Type:
Article
Add to My Research

Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission

Blood, 2024-05, Vol.143 (19), p.1931-1936 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023023096 ;PMID: 38364112

Full text available

16
Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis
Material Type:
Article
Add to My Research

Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis

Blood, 2024-05, Vol.143 (19), p.1937-1952 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023022666 ;PMID: 38446574

Full text available

17
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma
Material Type:
Article
Add to My Research

SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma

Blood, 2024-05, Vol.143 (19), p.1953-1964 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 American Society of Hematology ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023022241 ;PMID: 38237141

Full text available

18
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens
Material Type:
Article
Add to My Research

Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens

Blood, 2024-05, Vol.143 (18), p.1856-1872 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023022343 ;PMID: 38427583

Full text available

19
Kewan T, Bahaj W, Durmaz A, et al. Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes. Blood. 2023;141(14):1768-1772
Material Type:
Article
Add to My Research

Kewan T, Bahaj W, Durmaz A, et al. Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes. Blood. 2023;141(14):1768-1772

Blood, 2024-05, Vol.143 (18), p.1879-1879 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. 2024 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2024024464 ;PMID: 38696199

Full text available

20
Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy
Material Type:
Article
Add to My Research

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Blood, 2024-05, Vol.143 (18), p.1825-1836 [Peer Reviewed Journal]

2024 American Society of Hematology ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. ;2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023019706 ;PMID: 38211332

Full text available

Results 1 - 20 of 75,865  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (75,854)

Refine My Results

Creation Date 

From To
  1. Before 1964  (1,801)
  2. 1964 To 1978  (3,456)
  3. 1979 To 1993  (17,586)
  4. 1994 To 2009  (25,885)
  5. After 2009  (27,156)
  6. More options open sub menu

Language 

  1. English  (75,839)
  2. Japanese  (13,789)
  3. Russian  (43)
  4. French  (4)
  5. Norwegian  (4)
  6. Portuguese  (1)
  7. Swedish  (1)
  8. More options open sub menu

Searching Remote Databases, Please Wait